Metraipolis › archive › dc_66dbc29d99cc
A Pilot Study of Salmon Protein Hydrolysate (ProGo®) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health — Europe PMC PMID:42652046
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42652046
- DOI
- 10.3390/biomedicines14081663
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T19:57:07.361Z
- SHA-256 of the archived text
8d86275b427f2b4c809f64e230e66084da4cde922e23485edd00e7d0b4531161- Stable URL of this page
https://metraipolis.com/documento/dc_66dbc29d99cc
How to cite
A Pilot Study of Salmon Protein Hydrolysate (ProGo®) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health — Europe PMC PMID:42652046 — Europe PMC (en), https://europepmc.org/article/MED/42652046 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_66dbc29d99cc (Metraipolis archive dc_66dbc29d99cc, sha256 8d86275b427f2b4c809f64e230e66084da4cde922e23485edd00e7d0b4531161)
BibTeX
@misc{dc66dbc29d99cc,
title = {A Pilot Study of Salmon Protein Hydrolysate (ProGo®) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health — Europe PMC PMID:42652046},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42652046},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_66dbc29d99cc; sha256 8d86275b427f2b4c809f64e230e66084da4cde922e23485edd00e7d0b4531161},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652046. Agents can read the archived copy with the MCP tool read_document.